Skip to main content

Table 4 EORTC-C30 and -BN20 domain and single item's scores before and 6 months after VMAT

From: Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life

QoL

Pre-VMAT score ± SD

Score during VMAT ± SD

p value

C30

   

Global Health Status

62.5 ± 26.4

68.8 ± 20.8

0.47

Physical functioning

78.9 ± 22.9.6

71.9 ± 26.0

0.72

Emotional functioning

74.8 ± 20.1

70.0 ± 41.5

0.89

Role functioning

75.0 ± 21.6

73.3 ± 41.8

0.72

BN20 domains/items

   

Domains

   

Future uncertainty

26.0 ± 23.5

30.0 ± 41.5

0.72

Visual disorder

15.5 ± 12.7

28.9 ± 36.5

0.41

Motor dysfunction

15.5 ± 16.8

24.4 ± 30.8

0.59

Communication deficit

22.2 ± 28.3

6.6 ± 6.1

0.29

Single items

   

Headache

26.7 ± 43.5

20.0 ± 29.8

0.99

Hair loss

13.3 ± 29.8

0.0 ± 0.0

0.32

Weakness of legs

20.0 ± 18.2

26.6 ± 27.9

0.66

Bladder control

0.0 ± 0.0

0.0 ± 0.0

1.00

  1. Abbreviations: QoL: Quality of life; SD, standard deviation.